Oncolytics Biotech Inc.

Oncolytics Biotech Inc.

Healthcare

NASDAQ:ONCY · NASDAQ Capital Market

Market Cap $80.59M Beta 1.08 P/E (TTM) -3.6
$0.80 -2.07%

-$0.02 today

52W Low $0.54High $1.51

Vol 0.65M · Avg 1.22M

EPS (TTM)-$0.32
Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+32.07%

Period High

$1.42

Period Low

$0.61

Latest

$0.80

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
Immix Biopharma, Inc.

Immix Biopharma, Inc.

NASDAQ:IMMX

$459.70M

Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$266.95M

MacroGenics, Inc.

MacroGenics, Inc.

NASDAQ:MGNX

$251.71M

WH

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$205.72M

Surrozen, Inc.

Surrozen, Inc.

NASDAQ:SRZN

$174.90M

Coya Therapeutics, Inc.

Coya Therapeutics, Inc.

NASDAQ:COYA

$86.31M

Clene Inc.

Clene Inc.

NASDAQ:CLNN

$60.20M

Instil Bio, Inc.

Instil Bio, Inc.

NASDAQ:TIL

$53.71M

TV

Tevogen Bio Holdings Inc.

TVGN

$43.84M

AT

Atossa Therapeutics, Inc.

ATOS

$21.18M

What is the latest ONCY filing?

The latest filing shown is 3 dated Jun 3, 2026.

How many recent filings does ONCY have?

Intrinsic Alpha currently shows 20 recent filings for ONCY.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.